The estimated Net Worth of Ventures Inc.Vulcan Capital... is at least $25.9 Million dollars as of 25 June 2013. Ventures Capital owns over 333,333 units of PTC Therapeutics Inc stock worth over $25,914,972 and over the last 11 years Ventures sold PTCT stock worth over $0.
Ventures has made over 1 trades of the PTC Therapeutics Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Ventures bought 333,333 units of PTCT stock worth $4,999,995 on 25 June 2013.
The largest trade Ventures's ever made was buying 333,333 units of PTC Therapeutics Inc stock on 25 June 2013 worth over $4,999,995. On average, Ventures trades about 333,333 units every 0 days since 2013. As of 25 June 2013 Ventures still owns at least 803,067 units of PTC Therapeutics Inc stock.
You can see the complete history of Ventures Capital stock trades at the bottom of the page.
Over the last 12 years, insiders at PTC Therapeutics Inc have traded over $50,602,930 worth of PTC Therapeutics Inc stock and bought 3,730,934 units worth $57,374,337 . The most active insiders traders include Suisse/ Credit, Adam Koppel und Bioventures Cayman Ltd Hbm. On average, PTC Therapeutics Inc executives and independent directors trade stock every 16 days with the average trade being worth of $888,748. The most recent stock trade was executed by Pierre Gravier on 16 July 2024, trading 2,269 units of PTCT stock currently worth $77,191.
ptc is biopharmaceutical company focused on the discovery and development of orally-administered, proprietary small molecule drugs that target post-transcriptional control processes. while ptc’s discovery programs are directed at targets in multiple therapeutic areas, ptc is focusing particularly on the development and commercialization of treatments for orphan and ultra-orphan disorders. post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. ptc’s internally-discovered pipeline addresses multiple therapeutic areas, including neuromuscular disorders, oncology and infectious diseases. for more information on the company, please visit our website www.ptcbio.com.
PTC Therapeutics Inc executives and other stock owners filed with the SEC include: